Clinical trial
Neuropsychiatry and Cognition in the Context of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease (SCA3/MJD)
NCT04714307 is registered in ClinicalTrials.gov with Hospital de Clinicas de Porto Alegre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neuropsychiatry and Cognition in the Context of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease (SCA3/MJD)
- Lead sponsor
- Hospital de Clinicas de Porto Alegre
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 13, 2019
- Completion date
- August 1, 2023
- Enrollment
- 144 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
machado-joseph disease, mjd, sca3, spinocerebellar ataxia type 3